BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19486486)

  • 1. Doping use among young elite cyclists: a qualitative psychosociological approach.
    Lentillon-Kaestner V; Carstairs C
    Scand J Med Sci Sports; 2010 Apr; 20(2):336-45. PubMed ID: 19486486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health and doping in elite-level cycling.
    Lentillon-Kaestner V; Hagger MS; Hardcastle S
    Scand J Med Sci Sports; 2012 Oct; 22(5):596-606. PubMed ID: 21392123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Condemning and condoning: Elite amateur cyclists' perspectives on drug use and professional cycling.
    Outram SM; Stewart B
    Int J Drug Policy; 2015 Jul; 26(7):682-7. PubMed ID: 25666447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doing supplements to improve performance in club cycling: a life-course analysis.
    Stewart B; Outram S; Smith AC
    Scand J Med Sci Sports; 2013 Dec; 23(6):e361-72. PubMed ID: 23909650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary supplement and drug use and doping knowledge and attitudes in Italian young elite cyclists.
    Loraschi A; Galli N; Cosentino M
    Clin J Sport Med; 2014 May; 24(3):238-44. PubMed ID: 24184855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of doping use in high-level cycling: from team-organized doping to advances in the fight against doping.
    Lentillon-Kaestner V
    Scand J Med Sci Sports; 2013 Mar; 23(2):189-97. PubMed ID: 22092601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Doping in recreational sports activities--pills for better performance].
    Weiss J
    Dtsch Med Wochenschr; 2012 Jul; 137(30):p24. PubMed ID: 22872512
    [No Abstract]   [Full Text] [Related]  

  • 8. Doping and supplementation: the attitudes of talented young athletes.
    Bloodworth AJ; Petróczi A; Bailey R; Pearce G; McNamee MJ
    Scand J Med Sci Sports; 2012 Apr; 22(2):293-301. PubMed ID: 20973831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine consumption amongst British athletes following changes to the 2004 WADA prohibited list.
    Chester N; Wojek N
    Int J Sports Med; 2008 Jun; 29(6):524-8. PubMed ID: 18027309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accidental breaches of the doping regulations in sport: is there a need to improve the education of sportspeople?
    Somerville SJ; Lewis M; Kuipers H
    Br J Sports Med; 2005 Aug; 39(8):512-6; discussion 516. PubMed ID: 16046333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motives for illicit use of doping substances among athletes calling a national antidoping phone-help service: an exploratory study.
    Bilard J; Ninot G; Hauw D
    Subst Use Misuse; 2011; 46(4):359-67. PubMed ID: 20735214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of prolonged strenuous endurance exercise on the level of haematocrit in amateur cyclists.
    Neumayr G; Pfister R; Mitterbauer G; Gaenzer H; Joannidis M; Eibl G; Hoertnagl H
    Int J Sports Med; 2002 Apr; 23(3):158-61. PubMed ID: 11914976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerobic fitness variables do not predict the professional career of young cyclists.
    Menaspà P; Sassi A; Impellizzeri FM
    Med Sci Sports Exerc; 2010 Apr; 42(4):805-12. PubMed ID: 19952851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes.
    Ashenden MJ; Gore CJ; Parisotto R; Sharpe K; Hopkins WG; Hahn AG
    Haematologica; 2003 Sep; 88(9):1053-62. PubMed ID: 12969814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [General practitioners and doping in sports: knowledge and attitudes].
    Laure P
    Sante Publique; 1997 Jun; 9(2):145-56. PubMed ID: 9417372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A false start in the race against doping in sport: concerns with cycling's biological passport.
    Hailey N
    Duke Law J; 2011 Nov; 61(2):393-432. PubMed ID: 22069854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we measure accurately the prevalence of doping?
    Lentillon-Kaestner V; Ohl F
    Scand J Med Sci Sports; 2011 Dec; 21(6):e132-42. PubMed ID: 22126721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematocrit in elite athletes.
    Vergouwen PC; Collée T; Marx JJ
    Int J Sports Med; 1999 Nov; 20(8):538-41. PubMed ID: 10606218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.